Document 0855 DOCN M95A0855 TI Continuous secretion of human soluble CD4 in mice transplanted with genetically modified cells. DT 9510 AU Valere T; Bohl D; Klatzmann D; Danos O; Sonigo P; Heard JM; Institut Cochin de Genetique Moleculaire (ICGM-CNRS UPR415),; Paris, France. SO Gene Ther. 1995 May;2(3):197-202. Unique Identifier : AIDSLINE MED/95339005 AB Somatic transgenesis can be used to confer endogenous production of proteins with therapeutic properties. One such product, recombinant soluble human CD4 (sCD4), has been shown to be an efficient inhibitor of human immunodeficiency virus 1 (HIV-1) in vitro, but its too short half-life in vivo has impaired long-term clinical trials in AIDS patients. Using a retroviral vector, we introduced the cDNA of sCD4 into primary mouse fibroblasts. The cells were enclosed in a lattice of collagen and synthetic fibers coated with basic fibroblast growth factor, and implanted in the peritoneal cavity of syngeneic mice. Implantation of such sCD4-secreting organoids into cyclosporin A-treated C3H mice elicited a strong antibody response against sCD4. Implantation of sCD4-secreting organoids into immunotolerant mice (transgenic for transmembrane human CD4) resulted in continuous sCD4 production, detected during 60 days in animal sera. The serum levels obtained were significant, but too limited as yet for anti-HIV purposes. Nevertheless, this model may be of interest in various fields, as it provides the first demonstration that one potentially therapeutic protein, despite its half-life of a few hours, could remain present in vivo 2 months after a single somatic transgenesis. DE Animal Antibodies/BLOOD Antigens, CD4/*BIOSYNTHESIS/BLOOD/GENETICS/IMMUNOLOGY Cyclosporine Fibroblasts/TRANSPLANTATION *Gene Transfer Genetic Vectors/GENETICS Human Immunosuppression Male Mice Mice, Inbred C3H Mice, Inbred C57BL Mice, Transgenic Moloney Leukemia Virus/GENETICS Organoids/TRANSPLANTATION Recombinant Proteins/BIOSYNTHESIS/BLOOD/GENETICS/IMMUNOLOGY Support, Non-U.S. Gov't JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).